Form 4: ANI Pharma SVP Sells Shares Under 10b5-1 Plan

Krista Davis, SVP and Chief HR Officer of ANI Pharmaceuticals, sold 1,000 shares of common stock for $98.04 per share pursuant to a Rule 10b5-1 trading plan.

Summary

• Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, Inc. (ANIP), reported a sale of common stock.
• The transaction involved the disposition of 1,000 shares of common stock.
• The shares were sold at a price of $98.04 per share.
• The total value of the transaction was $98,040.
• Following this transaction, Krista Davis beneficially owns 60,186 shares of ANI Pharmaceuticals common stock.
• The sale was executed on September 19, 2025.
• This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.

Sentiment

Score: 5

Explanation: The filing is a standard Form 4 reporting an insider stock sale under a pre-arranged trading plan, which is a neutral event. It does not contain information that would typically indicate positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is solely a report of an insider transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, Krista Davis, insider trading, Form 4, stock sale, Rule 10b5-1, SVP, Chief HR Officer